Inactive Instrument
Peregrine Pharmaceuticals Share Price Nasdaq
Stocks
US7136613046
Pharmaceuticals
| Market Cap | 80Cr 69Cr 64Cr 59Cr 111.94Cr 7.63TCr 113.97Cr 762.89Cr 298.7Cr 3.79TCr 300.01Cr 293.44Cr 13TCr | P/E 2023 |
2,007x | P/E 2024 | -3.42x |
|---|---|---|---|---|---|
| Enterprise Value | 96Cr 84Cr 78Cr 72Cr 135.11Cr 9.21TCr 137.56Cr 920.77Cr 360.52Cr 4.57TCr 362.1Cr 354.17Cr 15TCr | EV / Sales 2023 |
8.58x | EV / Sales 2024 | 4.64x |
| Free-Float |
98.58% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2025 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 01/06/2026 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 80Cr | |
| +6.17% | +13.26% | +33.13% | -1.04% | 7.51TCr | |
| +2.67% | -9.35% | +17.09% | +176.95% | 4.76TCr | |
| +3.25% | +52.70% | +52.70% | +52.70% | 4.95TCr | |
| -3.81% | +6.32% | -54.61% | -54.17% | 4.29TCr | |
| -0.62% | +3.64% | +64.19% | -21.60% | 3.07TCr | |
| -3.23% | +5.40% | +58.59% | +94.94% | 2.49TCr | |
| +6.29% | +1.58% | +80.16% | -51.19% | 2.3TCr | |
| -1.59% | -3.61% | -11.53% | +150.58% | 1.96TCr | |
| +1.02% | +4.77% | +77.74% | +132.62% | 1.72TCr | |
| Average | +0.74% | +3.10% | +35.27% | +53.31% | 3.67TCr | |
| Weighted average by Cap. | +1.88% | +3.99% | +30.10% | +43.51% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 142.54Cr 56Cr 707.74Cr 56Cr 55Cr 2.38TCr | 14Cr 12Cr 11Cr 10Cr 20Cr 1.34TCr 20Cr 133.6Cr 52Cr 663.39Cr 53Cr 51Cr 2.23TCr |
| Net income | 6L 5L 5L 4L 8L 5.35Cr 8L 53.48L 20.94L 2.66Cr 21.03L 20.57L 8.93Cr | -14Cr -12Cr -11Cr -10Cr -20Cr -1.34TCr -20Cr -134.41Cr -53Cr -667.38Cr -53Cr -52Cr -2.24TCr |
| Net Debt | 15Cr 13Cr 12Cr 11Cr 21Cr 1.44TCr 22Cr 144.41Cr 57Cr 717.02Cr 57Cr 56Cr 2.41TCr | 17Cr 14Cr 13Cr 12Cr 23Cr 1.58TCr 24Cr 157.88Cr 62Cr 783.9Cr 62Cr 61Cr 2.64TCr |
Employees
-
Sector
Pharmaceuticals
